Foldes F F, Nagashima H, Boros M, Tassonyi E, Fitzal S, Agoston S
Br J Anaesth. 1983;55 Suppl 1:97S-103S.
The neuromuscular effects of three new nondepolarizing neuromuscular blocking drugs, atracurium, vecuronium and Duador, were investigated in surgical patients under balanced anaesthesia. (The numbers of patients in each study are given in the tables.) There were no significant differences in the neuromuscular effects of the three agents. None showed any cumulation after repeated administration of maintenance doses. Muscular relaxation for upper abdominal surgery was adequate as long as the isometric twitch tension (P) was no more than 25% of control. Conditions for tracheal intubation were satisfactory within less than 3 min after the start of injection. Spontaneous recovery of P to 90-95% of control, after the last dose of neuromuscular blocker was the fastest with vecuronium (35.8 +/- 2.4 min) and about the same with atracurium (54.3 +/- 2.4 min) and Duador (54.2 +/- 4.7 min). The T4/T1 ratio at the time of greater than 90% recovery of P was 0.44, 0.52 and 0.56 with vecuronium, Duador and atracurium, respectively, indicating the need for the reversal of the residual neuromuscular block. This could be accomplished within 2 min by the i.v. injection of edrophonium 0.5 mg kg-1, preceded by atropine 0.01 mg kg-1. No side-effects were observed with vecuronium. Atracurium caused mild to moderate histamine release in four of 50 patients included in this study, all of whom received an initial dose of 0.5 mg kg-1. The initial dose of Duador caused a 16.7% increase in heart rate. The findings indicate that the three new muscle relaxants merit further clinical trial. In our opinion, until the results of such studies become available, atracurium should not be used in patients with a history of allergic diathesis and Duador in those in whom increased heart rate may be harmful.
在平衡麻醉下,对接受手术的患者研究了三种新型非去极化神经肌肉阻滞药阿曲库铵、维库溴铵和杜阿多的神经肌肉效应。(每项研究中的患者数量列于表格中。)这三种药物的神经肌肉效应无显著差异。重复给予维持剂量后,均未显示出任何蓄积作用。只要等长收缩张力(P)不超过对照值的25%,上腹部手术的肌肉松弛就足够。注射开始后不到3分钟,气管插管条件令人满意。最后一剂神经肌肉阻滞剂后,维库溴铵使P自发恢复至对照值的90 - 95%最快(35.8±2.4分钟),阿曲库铵(54.3±2.4分钟)和杜阿多(54.2±4.7分钟)大致相同。P恢复超过90%时,维库溴铵、杜阿多和阿曲库铵的T4/T1比值分别为0.44、0.52和0.56,表明需要逆转残余的神经肌肉阻滞。静脉注射0.5mg/kg依酚氯铵,先注射0.01mg/kg阿托品,可在2分钟内完成。维库溴铵未观察到副作用。本研究纳入的50例患者中有4例使用阿曲库铵后出现轻度至中度组胺释放,所有这些患者均接受了0.5mg/kg的初始剂量。杜阿多的初始剂量使心率增加了16.7%。研究结果表明,这三种新型肌肉松弛剂值得进一步进行临床试验。我们认为,在获得此类研究结果之前,有过敏素质病史的患者不应使用阿曲库铵,心率增加可能有害的患者不应使用杜阿多。